Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Ovoca Bio Plc LSE:OVB London Ordinary Share IE00B4XVDC01 EUR0.125
  Price Change % Change Share Price Shares Traded Last Trade
  -0.25 -1.75% 14.00 94,449 09:00:28
Bid Price Offer Price High Price Low Price Open Price
13.50 14.50 14.25 14.00 14.25
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Mining -1.61 -162.48 11
Last Trade Time Trade Type Trade Size Trade Price Currency
12:31:02 O 60,000 13.55 GBX

Ovoca Bio (OVB) Latest News

More Ovoca Bio News
Ovoca Bio Takeover Rumours

Ovoca Bio (OVB) Discussions and Chat

Ovoca Bio Forums and Chat

Date Time Title Posts
13/9/202014:41Ovoca Bio...market cap Ј8.8, stake in Polymetal worth Ј14.8161
13/9/202014:41Viagra for women654

Add a New Thread

Ovoca Bio (OVB) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
12:31:0313.5560,0008,130.00O
11:17:5413.5510,0001,355.00O
10:03:5714.3568698.44O
07:59:2614.2020,0002,840.00O
07:57:0913.503,763508.01O
View all Ovoca Bio trades in real-time

Ovoca Bio (OVB) Top Chat Posts

DateSubject
22/9/2020
09:20
Ovoca Bio Daily Update: Ovoca Bio Plc is listed in the Mining sector of the London Stock Exchange with ticker OVB. The last closing price for Ovoca Bio was 14.25p.
Ovoca Bio Plc has a 4 week average price of 14p and a 12 week average price of 11.50p.
The 1 year high share price is 19.25p while the 1 year low share price is currently 6.75p.
There are currently 81,563,806 shares in issue and the average daily traded volume is 156,299 shares. The market capitalisation of Ovoca Bio Plc is £11,418,932.84.
28/8/2020
19:04
euclid5: Polymetal announces that on 25 August 2020 the Board of Directors of the Company resolved to pay an interim dividend of US$ 0.40 per share for the six months ended 30 June 2020 This brings the total dividend declared in 2020 to US$ 1.02 per share, or US$ 481 million in aggregate, and the dividend yield to 5.4% based on the average year-to-date share price. The dividend will be paid on 25 September 2020 Https://www.investegate.co.uk/polymetal--international-plc--poly-/eqs/polymetal--interim-dividend-declaration-of-us--0-40-per-share-and-approval-of-revised-dividend-policy/20200826070503EJYJQ/
05/8/2020
19:42
dave4545: 6.4% wow just checked myself. In a normal share world they could have sold them today and then RNS tomorrow to say they have and they have £10 mil cash. Imagine what that would do for the share price, instead since day 1 they sell in silence and then disclose in annual reports. Pr is always poor.
05/8/2020
09:45
imastu pidgitaswell: I don't disagree - just thinking that while it is cash burning, the increase in value of the POLY stake is really extending the period that it can undertake the development, rather than being a reason for the company value to rise (which is dependent on the efficacy of the drug.) Or put another way, the value of the liquid investment/cash does not affect the chances of the drug success - which is (possibly) why the share price remains unaffected. If they were to close the company today and return everything to shareholders, then it would be a factor - but that is not going to happen.
05/8/2020
09:36
imastu pidgitaswell: I would imagine it's simply being valued as a drugs play. The shareholding in POLY is simply the funding source - it will get spent, and the increase in value is just extending the time for which the funding source will be available. It's a very imaginative source (albeit more an accident/legacy) which is a whole lot better than cash, but still only a means to an end - this is not an investment vehicle for POLY (I hold their shares). Which is nice, but not really a reason for the share price here to increase - that is fundamentally an issue of the likelihood the drug working - or not (I have no opinion on that.)
12/3/2020
07:44
dave4545: tommy1 Yes it's frustrating the share price here but have a look around at other bio's, they are bumping along the bottom with little support and then they do 100-500% in a few days, so many have done this this year. So I will give Ovb the benefit of the doubt and wait impatiently for the next overdue update.
26/2/2020
21:34
dave4545: It certain does not help when a company has such terrible PR does it. People give up and it lets the mm's keep it in a narrow trading range for nearly 6 months. Despite the cash+Poly stake being worth close to double the current share price.
19/12/2019
20:11
ein4: New to this share but I think its a bargain, especially with the backing of its shares in Poly? The new venture in Bio concerning womens health looks exciting with a world wide application, providing it works, we will know soon? Have a look at the board , some serious players here , they are not here for a few pennies on the share price? I think you will see more buying tomorrow?
25/9/2019
08:37
newtothisgame3: Everything you need 2 know flying up 40% at open in Frankfurt leaking news coming #OVB #OVOCA #BIO MONEYBAGS FULL ARTICLE - TAKEOVER TIME OVOCA BIO WORTH DOUBLE ITS CURRENT SHARE PRICE Date: September 19, 2019 - Moneybags https://twitter.com/smallcappick/status/1175510617215643648
21/9/2019
21:47
newtothisgame3: TOP AIM STOCKS ‏https://twitter.com/smallcappick/status/1175510617215643648 @smallcappick 4m4 minutes ago More #OVB #OVOCA #BIO MONEYBAGS FULL ARTICLE - TAKEOVER TIME OVOCA BIO WORTH DOUBLE ITS CURRENT SHARE PRICE
20/9/2019
06:07
newtothisgame3: MONEYBAGS - OVOCA BIO WORTH DOUBLE ITS CURRENT SHARE PRICE Today 06:06 OVOCA BIO WORTH DOUBLE ITS CURRENT SHARE PRICE Date: September 19, 2019 - Moneybags https://www.thephoenix.ie/article/ovoca-bio-worth-double-its-current-share-price/
Ovoca Bio share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
OVB
Ovoca Bio
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200922 21:31:23